Brincidofovir (CMX001) 是 Cidofovir 的脂质结合前体药物，是一种口服、长效抗病毒药物。Brincidofovir 对广泛的 DNA 病毒具有活性，包括巨细胞病毒 (CMV)、腺病毒 (ADV)、水痘带状疱疹病毒、单纯疱疹病毒、多瘤病毒、乳头瘤病毒、痘病毒和混合双链 DNA 病毒感染。
| 生物活性 |
Brincidofovir (CMX001), the lipid-conjugated prodrug of Cidofovir , is an orally available, long-acting antiviral. Brincidofovir shows activity against a broad spectrum of DNA viruses including cytomegalovirus (CMV), adenovirus (ADV), varicella zoster virus, herpes simplex virus, polyomaviruses, papillomaviruses, poxviruses, and mixed double-stranded DNA virus infections. |
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 体内研究 |
Brincidofovir (BCV) (20 mg/kg; p.o.; on days 1, 3, 5, 7, 10, 14, 17, 21, and 24) extends survival in immune-deficient BALB/c nu/nu mice following lethal challenge with IHD-J-Luc VACV.
|
||||||||||||||||
| 分子式 |
C27H52N3O7P
|
||||||||||||||||
| 分子量 |
561.69
|
||||||||||||||||
| CAS号 |
444805-28-1
|
||||||||||||||||
| 运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |
||||||||||||||||
| 溶解性数据 |
In Vitro:
DMSO : 1 mg/mL (1.78 mM; adjust pH to 8 with NaOH and heat to 50°C) 配制储备液
|
||||||||||||||||
| 科研文献 |
纯度： ≥98%
咨询热线：
400-881-9290
Data Sheet
